Matches in SemOpenAlex for { <https://semopenalex.org/work/W2900515011> ?p ?o ?g. }
- W2900515011 endingPage "1834" @default.
- W2900515011 startingPage "1827" @default.
- W2900515011 abstract "Background Aortic stenosis (AS) is a common valvular abnormality and transcatheter aortic valve implantation (TAVI) is being increasingly used to treat patients considered too high risk for conventional surgery. We aimed to assess the prevalence of comorbid conditions in patients undergoing TAVI using the Charlson Comorbidity Index (CCI) and to assess their impact on clinical and procedural outcomes. Methods We analysed 158 patients who underwent a TAVI at our institution between June 2009 and September 2015 to define their co-morbid burden as measured with CCI, and study its impact on procedural characteristics and mortality at 30 days. Results One hundred fifty-eight (158) patients with a mean age of 82 ± 8 years and a mean CCI score of 2.67 underwent a TAVI. Only 12/158 patients had a CCI of 0. The commonest cardiovascular comorbidities were previous myocardial infarction (24%), congestive heart failure (15%) and diabetes mellitus (23%) whilst the commonest non-cardiovascular comorbidities were renal disease (46%) and chronic obstructive pulmonary disease (COPD) (29%). After multivariable adjustment, CCI was not independently associated with adverse clinical outcomes. The addition of CCI to scoring systems such as Logistic EuroScore (LES) and Society of Thoracic Surgeons (STS) risk models improved the area under the curve from 0.75 (95%CI: 0.44–1.00) and 0.83 (95%CI: 0.64–1.00) to 0.78 (95%CI: 0.53–1.00) and 0.89 (95%CI: 0.78–1.00) respectively. Conclusions The burden of comorbid conditions in patients undergoing TAVI is significant. The CCI score was not independently associated with a higher risk of death but can be useful in addition to LES and STS risk models in informing decision making on the selection of patients for TAVI. Aortic stenosis (AS) is a common valvular abnormality and transcatheter aortic valve implantation (TAVI) is being increasingly used to treat patients considered too high risk for conventional surgery. We aimed to assess the prevalence of comorbid conditions in patients undergoing TAVI using the Charlson Comorbidity Index (CCI) and to assess their impact on clinical and procedural outcomes. We analysed 158 patients who underwent a TAVI at our institution between June 2009 and September 2015 to define their co-morbid burden as measured with CCI, and study its impact on procedural characteristics and mortality at 30 days. One hundred fifty-eight (158) patients with a mean age of 82 ± 8 years and a mean CCI score of 2.67 underwent a TAVI. Only 12/158 patients had a CCI of 0. The commonest cardiovascular comorbidities were previous myocardial infarction (24%), congestive heart failure (15%) and diabetes mellitus (23%) whilst the commonest non-cardiovascular comorbidities were renal disease (46%) and chronic obstructive pulmonary disease (COPD) (29%). After multivariable adjustment, CCI was not independently associated with adverse clinical outcomes. The addition of CCI to scoring systems such as Logistic EuroScore (LES) and Society of Thoracic Surgeons (STS) risk models improved the area under the curve from 0.75 (95%CI: 0.44–1.00) and 0.83 (95%CI: 0.64–1.00) to 0.78 (95%CI: 0.53–1.00) and 0.89 (95%CI: 0.78–1.00) respectively. The burden of comorbid conditions in patients undergoing TAVI is significant. The CCI score was not independently associated with a higher risk of death but can be useful in addition to LES and STS risk models in informing decision making on the selection of patients for TAVI." @default.
- W2900515011 created "2018-11-29" @default.
- W2900515011 creator A5005219054 @default.
- W2900515011 creator A5013165879 @default.
- W2900515011 creator A5023686523 @default.
- W2900515011 creator A5025739331 @default.
- W2900515011 creator A5026108472 @default.
- W2900515011 creator A5044010951 @default.
- W2900515011 creator A5055355968 @default.
- W2900515011 creator A5057514332 @default.
- W2900515011 creator A5077375809 @default.
- W2900515011 creator A5086194417 @default.
- W2900515011 date "2019-12-01" @default.
- W2900515011 modified "2023-09-27" @default.
- W2900515011 title "The Influence of the Charlson Comorbidity Index on Procedural Characteristics, VARC-2 Endpoints and 30-Day Mortality Among Patients Who Undergo Transcatheter Aortic Valve Implantation" @default.
- W2900515011 cites W1560998933 @default.
- W2900515011 cites W1575075233 @default.
- W2900515011 cites W1748401486 @default.
- W2900515011 cites W1848059244 @default.
- W2900515011 cites W1931033851 @default.
- W2900515011 cites W1934170202 @default.
- W2900515011 cites W1969092506 @default.
- W2900515011 cites W1970667076 @default.
- W2900515011 cites W1987285191 @default.
- W2900515011 cites W1994115987 @default.
- W2900515011 cites W2000445173 @default.
- W2900515011 cites W2000967076 @default.
- W2900515011 cites W2001905888 @default.
- W2900515011 cites W2011528666 @default.
- W2900515011 cites W2011968584 @default.
- W2900515011 cites W2014620945 @default.
- W2900515011 cites W2024543886 @default.
- W2900515011 cites W2053564483 @default.
- W2900515011 cites W2056310152 @default.
- W2900515011 cites W2073662220 @default.
- W2900515011 cites W2118924838 @default.
- W2900515011 cites W2122694177 @default.
- W2900515011 cites W2130501785 @default.
- W2900515011 cites W2133164532 @default.
- W2900515011 cites W2140726941 @default.
- W2900515011 cites W2149366487 @default.
- W2900515011 cites W2149609916 @default.
- W2900515011 cites W2163978931 @default.
- W2900515011 cites W2165139489 @default.
- W2900515011 cites W2165258820 @default.
- W2900515011 cites W2168789996 @default.
- W2900515011 cites W2171941165 @default.
- W2900515011 cites W2308990022 @default.
- W2900515011 cites W2328176404 @default.
- W2900515011 cites W2401594814 @default.
- W2900515011 cites W2795803030 @default.
- W2900515011 cites W2885750278 @default.
- W2900515011 cites W4232761266 @default.
- W2900515011 cites W48844573 @default.
- W2900515011 doi "https://doi.org/10.1016/j.hlc.2018.11.006" @default.
- W2900515011 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30528813" @default.
- W2900515011 hasPublicationYear "2019" @default.
- W2900515011 type Work @default.
- W2900515011 sameAs 2900515011 @default.
- W2900515011 citedByCount "7" @default.
- W2900515011 countsByYear W29005150112021 @default.
- W2900515011 countsByYear W29005150112022 @default.
- W2900515011 countsByYear W29005150112023 @default.
- W2900515011 crossrefType "journal-article" @default.
- W2900515011 hasAuthorship W2900515011A5005219054 @default.
- W2900515011 hasAuthorship W2900515011A5013165879 @default.
- W2900515011 hasAuthorship W2900515011A5023686523 @default.
- W2900515011 hasAuthorship W2900515011A5025739331 @default.
- W2900515011 hasAuthorship W2900515011A5026108472 @default.
- W2900515011 hasAuthorship W2900515011A5044010951 @default.
- W2900515011 hasAuthorship W2900515011A5055355968 @default.
- W2900515011 hasAuthorship W2900515011A5057514332 @default.
- W2900515011 hasAuthorship W2900515011A5077375809 @default.
- W2900515011 hasAuthorship W2900515011A5086194417 @default.
- W2900515011 hasBestOaLocation W29005150112 @default.
- W2900515011 hasConcept C126322002 @default.
- W2900515011 hasConcept C134018914 @default.
- W2900515011 hasConcept C141071460 @default.
- W2900515011 hasConcept C164705383 @default.
- W2900515011 hasConcept C2776780178 @default.
- W2900515011 hasConcept C2778198053 @default.
- W2900515011 hasConcept C2779159551 @default.
- W2900515011 hasConcept C2780007028 @default.
- W2900515011 hasConcept C3019063607 @default.
- W2900515011 hasConcept C500558357 @default.
- W2900515011 hasConcept C555293320 @default.
- W2900515011 hasConcept C71924100 @default.
- W2900515011 hasConceptScore W2900515011C126322002 @default.
- W2900515011 hasConceptScore W2900515011C134018914 @default.
- W2900515011 hasConceptScore W2900515011C141071460 @default.
- W2900515011 hasConceptScore W2900515011C164705383 @default.
- W2900515011 hasConceptScore W2900515011C2776780178 @default.
- W2900515011 hasConceptScore W2900515011C2778198053 @default.
- W2900515011 hasConceptScore W2900515011C2779159551 @default.
- W2900515011 hasConceptScore W2900515011C2780007028 @default.
- W2900515011 hasConceptScore W2900515011C3019063607 @default.
- W2900515011 hasConceptScore W2900515011C500558357 @default.
- W2900515011 hasConceptScore W2900515011C555293320 @default.